Axsome Therapeutics (AXSM) FCF Margin Growth (1y) (2023 - 2026)
Axsome Therapeutics (AXSM) FCF Margin Growth (1y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,981.90 Bn | 66,981.62 Bn | - | - |
| 2 | Nanobiotix | 1,924.26 Bn | 1,924.20 Bn | - | - |
| 3 | Akari Therapeutics | 975.59 Bn | 975.59 Bn | - | - |
| 4 | BeOne Medicines | 472.11 Bn | 467.32 Bn | 1.35 Bn | 1,187.00 |
| 5 | Vertex Pharmaceuticals | 121.89 Bn | 114.65 Bn | 2.59 Bn | 1,525.00 |
| 6 | Regeneron Pharmaceuticals | 69.93 Bn | 61.18 Bn | 3.31 Bn | -341.00 |
| 7 | Belite Bio | 62.83 Bn | 62.83 Bn | - | - |
| 8 | Argenx Se | 55.82 Bn | 50.63 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.49 Bn | 37.49 Bn | - | - |
| 10 | Axsome Therapeutics | 12.32 Bn | 12.02 Bn | 176.48 Mn | 2,510.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2,510.00 |
| Dec 31, 2025 | 523,685.00 |
| Sep 30, 2025 | 1,845.00 |
| Jun 30, 2025 | 1,298.00 |
| Mar 31, 2025 | 3,543.00 |
| Dec 31, 2024 | -520,394.00 |
| Sep 30, 2024 | 7,543.00 |
| Jun 30, 2024 | 8,420.00 |
| Mar 31, 2024 | -6,519.00 |
| Dec 31, 2023 | 7,138.00 |
| Sep 30, 2023 | 4,219.00 |
| Jun 30, 2023 | 26,417.00 |